Table 2 The prognostic significance of ALDH3B2 and clinicopathological characteristics in CCA.

From: Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression

Characteristics

iCCA

pCCA

dCCA

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

3-year OS

pa

HR

pb

3-year OS

pa

HR

pb

3-year OS

pa

HR

pb

Age (years)

<60

36.5

0.132

  

41.9

0.029

1

 

45.4

0.127

  

≥60

9.1

   

21.6

 

2.355

0.009

32.6

   

Gender

male

31.3

0.794

  

32.6

0.358

  

30.7

0.364

  

female

18.2

   

20.5

   

47.2

   

Tumor size

<3 cm

14.3

0.246

  

33.8

0.157

  

37.9

0.131

  

≥3 cm

28.6

   

21.0

   

29.6

   

Differentiation

Well/moderate

23.4

0.710

  

32.3

0.051

1

 

41.0

0.554

  

Poor

27.3

   

21.9

 

1.874

0.036

29.3

   

T stage

T1/T2

34.3

0.032

1

 

29.7

0.014

1

 

47.8

0.009

1

 

T3/T4

0

 

2.708

0.041

0

 

3.822

0.022

26.6

 

1.648

0.084

N stage

N0

29.3

0.083

1

 

40.4

0.003

1

 

39.3

0.032

1

 

N1/N2

0

 

0.890

0.885

5.5

 

1.381

0.334

30.9

 

1.418

0.256

M stage

M0

29.8

0.252

  

33.7

<0.001

1

 

38.0

<0.001

1

 

M1

0

   

0

 

2.788

0.008

0

 

3.588

0.048

TNM stage

I/II

34.3

0.032

  

37.5

0.004

  

36.4

0.204

  

III/IV

0

   

7.1

   

42.1

   

Neural invasion

Negative

21.8

0.348

  

42.1

0.221

  

48

0.006

1

 

Positive

40.0

   

19.3

   

28.3

 

1.994

0.021

CEA (ng/ml)

<10

35.5

0.006

1

 

30.4

0.022

1

 

38.2

0.070

1

 

≥10

0

 

2.003

0.214

0

 

2.630

0.027

0

 

1.817

0.292

CA19-9 (U/mL)

<100

43.6

0.027

1

 

36.1

0.020

1

 

47.7

0.108

  

≥100

12.5

 

2.619

0.054

22.6

 

1.182

0.586

25.8

   

ALDH3B2

Low

38.5

0.038

1

 

36.9

0.001

1

 

42.3

0.025

1

 

High

10.7

 

2.542

0.047

16.3

 

1.905

0.042

28.5

 

1.590

0.096

  1. ALDH3B2 aldehyde dehydrogenase 3B2, CCA cholangiocarcinoma, OS overall survival, HR hazard ratio.
  2. a Calculated by log-rank test.
  3. b Calculated by Cox-regression Hazard model.